Save the Date 📌 Swiss Dementia Forum 2027 The conversations started in 2025 will continue in November 2027. We look forward to bringing together the Swiss dementia community once again to connect research, treatment and care. #SDF27 #DementiaResearch #DementiaCare

What is the role of neuropsychology when biology and cognition no longer tell the same story? Join Alexia Candal-Zürcher (Inselspital Bern) in our Dementia update – Clinical Series. 📆 10.09.2026 | 🕛 12:00 Register here: swiss-dementia-network.ch/events/demen...

#DementiaConnectBern is getting closer! Join researchers and clinical professionals on 25 September 2026 to discuss current perspectives on dementia research and care. Submit your abstract for the Poster Session by 21 August. 🔗 swiss-dementia-network.ch/events/demen...

Join our next Dementia Update webinar with Prof. Dr. med. Giorgia Melli (USI) on early Parkinson’s diagnosis. Discover how extracellular vesicles and machine learning could enable earlier, more precise diagnosis. 27 Aug 2026 | 16:00–16:45

Join PD Dr. med. @orouaud1.bsky.social (Leenaards Memory Center) to discuss clinical assessment, complementary tools & differential diagnosis for patients with dementia under 65.

A short summer break before the next season of the SNDR #DementiaUpdateSeries. From August onwards, our Virtual and Clinical Series return with new topics, speakers and opportunities for interdisciplinary exchange. Take a look at the attached program for an autumn preview.

Dementia research in Switzerland is evolving fast – we help you stay oriented. Subscribe to our monthly newsletter: swiss-dementia-network.ch/newsletter-s...

𝗛𝗼𝘄 𝗱𝗼𝗲𝘀 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗶𝗺𝗮𝗴𝗶𝗻𝗴 𝗱𝗿𝗶𝘃𝗲 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁? Join Dementia Update – Virtual Series #16 with Prof. Valentina Garibotto (University of Geneva) on 25 June 2026 at 4pm. Register here: swiss-dementia-network.ch/events/demen...

Join our Clinical Series with PD Dr. Mathias Schlögl on 11th of June to learn practical strategies to recognize agitation in dementia as a clinical symptom, identify unmet needs and implement non-pharmacological and psychopharmacological treatments.

Can we rejuvenate the aging brain?@graeffjohannes.bsky.social presents research on partial reprogramming of memory-storing neurons using OSK gene therapy to reverse age-related changes and improve cognition in aging and Alzheimer’s disease models.

READ💡Our latest blog post from the Dementia Updates Series explores how biological, social and structural factors shape Alzheimer’s risk across the life course — from #menopause and cardiometabolic health to sex, gender and #socioeconomic factors. swiss-dementia-network.ch/news/webinar...

Diagnosing #FTD is tricky – but not impossible. 🧠 Prof. Marc Sollberger shares how Switzerland’s #SwissFTDNetwork is bringing neurologists, psychiatrists and other specialists together to improve early diagnosis and patient care. Full interview: swiss-dementia-network.ch/news/intervi...

Cell type specific composition of brain APOE particles 🧠 Discover how the origin of APOE particles differ depending on cellular origin, revealing new insights into Alzheimer’s. Join Evelina Voloviceva in the Dementia Update – Virtual Series. #Alzheimers #BrainHealth #DementiaUpdate

What if dementia prevention started in the community, not the clinic? Join Dr. Federica Ribaldi & Prof. Bogdan Draganski to explore integrated models for brain health, from public workshops to personalized risk reduction. #DementiaPrevention #BrainHealth swiss-dementia-network.ch/events/demen...

Swissmedic has approved Donanemab — the first disease-modifying therapy for Alzheimer’s in Switzerland. But is our healthcare system ready for anti-amyloid therapies and ARIA? Read our latest blog on implementation lessons from two experts. swiss-dementia-network.ch/news/webinar...

Dr. Sivaniya Subramaniapillai explores how biology, social factors & structural inequalities — like sex, genetics, socioeconomic status & discrimination — combine to shape brain aging & dementia, and how intersectional approaches can support fairer risk models & care.

How does menopause shape brain health and dementia risk? Dr. Louise Schindler explores hormonal shifts, cardiometabolic changes, and what they mean for future research and clinical practice. Join the next Dementia Update – Clinical Series: swiss-dementia-network.ch/events/demen...

#Demenz – Ein neu entwickeltes Pflegekonzepts kann die Lebensqualität Betroffener verbessern, der Einsatz von Psychopharmaka kann dabei reduziert oder gar vermieden werden. Dies zeigt eine neue Studie der Uni Luzern. www.unilu.ch/news/vida-co...

Neues Pflegekonzept verbessert Lebensqualität Demenzbetroffener

Steigende Demenzfallzahlen und Grenzen medikamentöser Behandlungen unterstreichen die Bedeutung wirksamer Pflegekonzepte. Eine neue Studie zeigt nun, dass das im Haus Herbschtzytlos entwickelte Konzep...

unilu.ch

After careful review, @swissmedic.bsky.social has officially approved #Donanemab for Alzheimer’s disease on 4 February 2026. This marks an important milestone for Alzheimer’s therapy in Switzerland. Timely with this approval, we are hosting a webinar on #ARIA prediction, detection and management!

🧠 Predicting & managing ARIA is key in Alzheimer’s care. PD Dr. Piotr Radojewski shares image-based strategies and clinical insights, with interactive Q&A, hosted by Prof. Bogdan Draganski. 📅 12.02.26 | 🕓 12:00–11:50 Register here: swiss-dementia-network.ch/events/demen...

New 3D whole-brain mapping tool for Parkinson’s 🧠 Developed at UZH in collaboration with teams from Johns Hopkins & Marburg, PDMap3D allows researchers to visualize pathology across the entire mouse brain. Method publicly available — discover & share tools on our platform!

Season’s greetings from the Team 🎄 We hope this year’s season fills your days with the things that mean most to you and energizes you for a happy and healthy new year.

🧬 Abnormal tau disrupts neuron energy & communication. Dr. Grimm shows how healthy mitochondrial transplants can restore function and boost neurite growth – a promising path for Alzheimer’s therapies. 📅 30.10.2025 | 🕓 16:00–16:45 Register here: swiss-dementia-network.ch/events/demen...

Your Lunch Break, Upgraded! 🧠 A new spin-off of the Dementia Update series, in collaboration with Swiss Memory Clinics. 50 min of insight & inspiration for clinicians & researchers. Starting 15 Jan 2026, every 2nd Thu at 12 pm CET. Learn more: swiss-dementia-network.ch/events/webin...

The #SwissDementiaForum 2025 was inspiring! Thank you to everyone who made it happen. New research, great discussions and meaningful connections — together, we make a difference. Full recap: swiss-dementia-network.ch/news/swiss-d...

Thank you to 250+ participants, our keynote speakers, and the Event Forum team for an inspiring Swiss Dementia Forum.

How close are we to understanding neurodegenerative diseases? Join us at the @lifesciswitzerland.bsky.social (LS2) Annual Meeting – with top researchers like Britta Engelhardt and @marcaurelbusche.bsky.social, and discussions led by Daniela Noain & @bogdandraganski.bsky.social.

🚨 Abstract deadline extended! LS2 Annual Meeting 2026: 📍 Zürich | 🗓 Feb 11–12 (YSS: Feb 10) Join us for keynotes by Sarah-Maria Fendt, Heidi McBride & Jennifer Lippincott-Schwartz + 11 symposia, poster session, & networking. 🔗 Abstracts due Nov 16: annual-meeting.ls2.ch/2026/registr...

🚀 #ERAAD2026 | 1–5 March, Italy Early-career researchers: dive into state-of-the-art Alzheimer’s science, world-class mentorship, and career-boosting workshops. Sponsored by Dementia Research Switzerland – Synapsis Foundation. era-ad2026.azuleon.org/welcome

Fully booked 💥 one day ahead of schedule! Registration for the Swiss Dementia Forum 2025 is now closed. We’re thrilled and grateful for the incredible response — every spot filled a day before the official closing. See you soon in Bern! #SwissDementiaForum #DementiaResearch